Navigation Links
FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery
Date:6/19/2013

(PRWEB) June 19, 2013

The US Food and Drug Administration (FDA) announced last week the approval of a third ultra cohesive gel breast implant, Mentor Worldwide’s MemoryShape™.

The FDA approved Sientra/Silimed in March 2012 and Allergan 410 in February 2013. The FDA announced the approval of the MemoryShape™ implant on June 14, 2013. It is approved for primary augmentations in women 22 years old or older and in breast reconstruction of women of any age.

The FDA’s approval comes after six years of data from 955 women participating in trials. Dr. Joseph Bauer of the Swan Center for Plastic Surgery was one of the select plastic surgeons involved in the FDA trials, and he is now pleased to offer the newest breast implants to his patients. Dr. Bauer says, “The Mentor MemoryShape™ ultra cohesive implants are another option for women considering plastic surgery. It’s exciting to have so many options for creating very individualized surgeries.”

All three of the approved ultra cohesive implants require a high level of surgical skill and experience. The Swan Center for Plastic Surgery is a leader in the United States for volume of breast augmentations they perform, and all three staff plastic surgeons are board certified in plastic surgery and helped implement the FDA trial studying the cohesive gel implants. Patients should look for this level of qualifications in the plastic surgeon they choose for their augmentation.

The surgeons at the Swan Center for Plastic Surgery are proponents of educating patients for higher levels of discussion and decision-making and for better expectations for surgical results.

Dr. Bauer comments, “With FDA approval of a third “gummy bear” implant, women have choices for a safe and natural-looking, tear drop shape.”

All three ultra cohesive gel breast implants are offered at The Swan Center for Plastic Surgery.

About The Swan Center:

The Swan Center for Plastic Surgery is a leader in the aesthetic industry specializing in surgery of the breast, body and face.

The Swan Center for Plastic Surgery’s on site operating facility, Alpharetta Aesthetic Center is accredited by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). The Joint Commission is an independent, not-for-profit organization; and is the nation's oldest and largest standards-setting and accrediting body in health care, focusing on patient safety and quality of care. The plastic surgeons at The Swan Center are board-certified by the American Board of Plastic Surgery, among a multitude of further professional accomplishments.

Swan Center for Plastic Surgery
4165 Old Milton Parkway, Suite 200 East
Alpharetta, GA 30005
http://www.swancenteratlanta.com
(770) 667-0904 or 800-816-1057

Read the full story at http://www.prweb.com/releases/ultra/cohesive/prweb10845621.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. FDA Approved Home Ultrasound Machine Discounted Online
2. Myrtle Beach Urology Groups Administer First Commercial Dose of Newly FDA Approved Prostate Cancer Treatment
3. SafeToSleep Baby Monitor Wins Parent Tested Parent Approved (PTPA) Award
4. South Carolina Association of Veterinarians is Approved Provider of Education for New York Veterinarians and Veterinary Technicians
5. $40 Million Class-Action Skechers Lawsuit Settlement Approved by Federal Judge, Reports Wright & Schulte LLC
6. Wartrol Genital Warts Relief Formula Now Comes With FDA Approved Ingredients for Fast Actions at HerbalRemediezInc.com
7. American Academy of Personal Training Now Approved By The US Department of Education To Offer Low Cost Financial Aid
8. Wartrol Warts Relief Formula Now Comes With FDA Approved Ingredients For Fast Actions
9. FDA Approved Treatment for Painful Intercourse (Dyspareunia) Due to Menopause
10. ASHA Approved Continuing Education Provider HomeCEUConnection.com Announces Two New Live, Interactive Webinars for California Speech-Language Pathologists.
11. EzW2Correction Software Was Approved By SSA To Print W-2C and W-3C On White Paper
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology: